Variable | Unfav | Fav | OR (95 % CI) | P Value | Variable | Unfav | Fav | OR (95 % CI) | P Value |
---|---|---|---|---|---|---|---|---|---|
Sex | Â | Â | Â | Â | Headache | Â | Â | Â | Â |
 Male | 18 | 27 | 0.44 (0.18–1.10) | 0.08 | Yes | 31 | 28 | 1.80 (0.65–4.98) | 0.26 |
 Female | 21 | 14 |  |  | No | 8 | 13 |  |  |
Age, years | Â | Â | Â | Â | Irritability | Â | Â | Â | Â |
 > 60 | 10 | 6 | 2.01 (0.65–6.20) | 0.22 | Yes | 6 | 17 | 0.26 (0.09–0.75) | 0.01 |
 ≤ 60 | 29 | 35 |  |  | No | 33 | 24 |  |  |
Duration of Symptoms, days | Â | Â | Â | Â | Nausea and vomiting | Â | Â | Â | Â |
 > 10 | 32 | 30 | 1.68 (0.58–4.89) | 0.34 | Yes | 23 | 24 | 1.02 (0.42–2.48) | 0.97 |
 ≤ 10 | 7 | 11 |  |  | No | 16 | 17 |  |  |
ICU stay, days |  |  |  |  | Fever(≥ 38.5℃) |  |  |  |  |
 > 15 | 12 | 18 | 0.57 (0.23–1.42) | 0.23 | Yes | 28 | 32 | 0.72 (0.26–1.98) | 0.52 |
 ≤ 15 | 27 | 23 |  |  | No | 11 | 9 |  |  |
Immune deficiency | Â | Â | Â | Â | Neck stiffness | Â | Â | Â | Â |
 Yes | 10 | 5 | 2.48 (0.76–8.08) | 0.13 | Yes | 32 | 35 | 0.78 (0.24–2.58) | 0.69 |
 No | 29 | 36 |  |  | No | 7 | 6 |  |  |
Old tuberculosis | Â | Â | Â | Â | Convulsions | Â | Â | Â | Â |
 Yes | 5 | 2 | 2.87 (0.52–15.75) | 0.23 | Yes | 9 | 6 | 1.75 (0.56–5.49) | 0.34 |
 No | 34 | 39 |  |  | No | 30 | 35 |  |  |
Active extra-neuraltuberculosis | Â | Â | Â | Â | Focal neurologicaldeficits | Â | Â | Â | Â |
 Yes | 20 | 21 | 0.95 (0.39–2.30) | 0.91 | Yes | 20 | 23 | 1.21 (0.50–2.93) | 0.67 |
 No | 19 | 20 |  |  | No | 19 | 18 |  |  |
Alteredconsciousness | Â | Â | Â | Â | Basal meningealenhancement | Â | Â | Â | Â |
 Yes | 33 | 37 | 0.60 (0.15–2.29) | 0.45 | Yes | 5 | 5 | 1.10 (0.29–4.18) | 0.89 |
 No | 6 | 4 |  |  | No | 30 | 33 |  |  |
Lethargy | Â | Â | Â | Â | Hydrocephalus | Â | Â | Â | Â |
 Yes | 32 | 36 | 0.64 (0.18–2.20) | 0.47 | Yes | 25 | 20 | 2.25 (0.85–5.94) | 0.10 |
 No | 7 | 5 |  |  | No | 10 | 18 |  |  |
GCS | Â | Â | Â | Â | Infarct | Â | Â | Â | Â |
 ≤ 4 | 32 | 29 | 1.89 (0.66–5.45) | 0.24 | Yes | 20 | 16 | 1.83 (0.72–4.64) | 0.20 |
 > 4 | 7 | 12 |  |  | No | 15 | 22 |  |  |
APACHE II | Â | Â | Â | Â | Tuberculoma | Â | Â | Â | Â |
 ≤ 23 | 13 | 29 | 0.21 (0.08–0.53) | 0.001 | Yes | 3 | 1 | 3.47 (0.34–35.02) | 0.29 |
 > 23 | 26 | 12 |  |  | No | 32 | 37 |  |  |
SOFA | Â | Â | Â | Â | MV | Â | Â | Â | Â |
 ≤ 8 | 23 | 39 | 0.07 (0.02–0.35) | 0.001 | Yes | 37 | 21 | 17.62(3.74–82.93) | < 0.001 |
 > 8 | 16 | 2 |  |  | No | 2 | 20 |  |  |
Positive culture inCSF | Â | Â | Â | Â | Pre-contrast basalhyperdensity | Â | Â | Â | Â |
 Yes | 13 | 9 | 1.85 (0.68–5.02) | 0.23 | Yes | 4 | 2 | 2.32 (0.40-13.55) | 0.35 |
 No | 25 | 32 |  |  | No | 31 | 36 |  |  |
Positive PCR in CSF | Â | Â | Â | Â | Surgical intervention | Â | Â | Â | Â |
 Yes | 11 | 10 | 1.31 (0.48–3.57) | 0.60 | Yes | 7 | 4 | 2.02 (0.54–7.55) | 0.29 |
 No | 26 | 31 |  |  | No | 32 | 37 |  |  |